Agent drug coated balloon
Ended Awarded Last action
- Contract number
- SPE2D626F429L
- Awardee
-
Boston Scientific Corp UEI YWDHHW3DLNQ1
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $145,885
Award facts
- Contract value 100% obligated
- $145,885.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition after exclusion of sources Negotiated Proposal / Quote
- Pricing
- Fixed Price with Economic Price Adjustment
- Place of performance
- Marlborough, MA 01752, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Health Agency's Medical Supply Chain awarded a $145,885.28 fixed-price delivery order to Boston Scientific Corp for Agent drug-coated balloons. This delivery order, issued on November 24, 2025, with an ultimate completion date of December 2, 2025, represents an order against Boston Scientific's broader supply relationship with the Defense Health Agency for specialized interventional cardiology devices. Boston Scientific, headquartered in Marlborough, Massachusetts, is a global medical technology company and the performance location for this contract. The award carries no small business set-aside designation, allowing Boston Scientific to compete on an unrestricted basis. Drug-coated balloons are critical interventional cardiology devices used in percutaneous coronary intervention procedures to prevent restenosis and are routinely procured by federal healthcare agencies serving military personnel and beneficiaries.
This delivery order falls within Boston Scientific's extensive federal contracting relationship with the Defense Health Agency and Veterans Health Administration, where the company serves as a critical supplier of advanced cardiovascular and interventional medical devices. Boston Scientific's established presence as a federal contractor across multiple Veterans Integrated Service Networks and the Defense Health Agency, combined with its specialized expertise in drug-coated balloon technology and other coronary intervention devices, positions it as a primary vendor for these procurement requirements. The compressed timeline from award to completion reflects the urgent resupply nature typical of delivery orders issued against existing blanket purchase agreements or indefinite delivery contracts supporting ongoing clinical operations across the federal healthcare system.
Quick answers
Who was awarded contract SPE2D626F429L?
SPE2D626F429L was awarded to Boston Scientific Corp by Medical Supply Chain (Troop Support) on November 24, 2025.
How much is contract SPE2D626F429L worth?
The government has obligated $145,885 on SPE2D626F429L.
Is contract SPE2D626F429L an order under another contract?
Yes. SPE2D626F429L is a delivery order under SPE2DE21D7020, an indefinite delivery contract.
Was contract SPE2D626F429L competed?
The extent of competition for SPE2D626F429L was full and open competition after exclusion of sources.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award